BE820660A - Procede de detection d'antigenes ou d'anticorps - Google Patents

Procede de detection d'antigenes ou d'anticorps

Info

Publication number
BE820660A
BE820660A BE149173A BE149173A BE820660A BE 820660 A BE820660 A BE 820660A BE 149173 A BE149173 A BE 149173A BE 149173 A BE149173 A BE 149173A BE 820660 A BE820660 A BE 820660A
Authority
BE
Belgium
Prior art keywords
antigen
detection process
antibody detection
antibody
detection
Prior art date
Application number
BE149173A
Other languages
English (en)
French (fr)
Inventor
I Bornstein
A Kapsalis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE820660A publication Critical patent/BE820660A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
BE149173A 1973-10-26 1974-10-03 Procede de detection d'antigenes ou d'anticorps BE820660A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/410,066 US3949064A (en) 1973-10-26 1973-10-26 Method of detecting antigens or antibodies

Publications (1)

Publication Number Publication Date
BE820660A true BE820660A (fr) 1975-02-03

Family

ID=23623067

Family Applications (1)

Application Number Title Priority Date Filing Date
BE149173A BE820660A (fr) 1973-10-26 1974-10-03 Procede de detection d'antigenes ou d'anticorps

Country Status (15)

Country Link
US (2) US3949064A (cg-RX-API-DMAC7.html)
JP (1) JPS5762020B2 (cg-RX-API-DMAC7.html)
AU (1) AU476619B2 (cg-RX-API-DMAC7.html)
BE (1) BE820660A (cg-RX-API-DMAC7.html)
BR (1) BR7408886A (cg-RX-API-DMAC7.html)
CA (1) CA1036493A (cg-RX-API-DMAC7.html)
DE (1) DE2450523C3 (cg-RX-API-DMAC7.html)
ES (1) ES431413A1 (cg-RX-API-DMAC7.html)
FR (1) FR2249334B1 (cg-RX-API-DMAC7.html)
GB (1) GB1436934A (cg-RX-API-DMAC7.html)
IL (1) IL45707A (cg-RX-API-DMAC7.html)
LU (1) LU71027A1 (cg-RX-API-DMAC7.html)
NL (1) NL7413552A (cg-RX-API-DMAC7.html)
SE (1) SE7413484L (cg-RX-API-DMAC7.html)
ZA (1) ZA746098B (cg-RX-API-DMAC7.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172117A (en) * 1974-05-20 1979-10-23 Biotest-Serum-Institut Gmbh Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US4225784A (en) * 1976-06-17 1980-09-30 Smith Kline Instruments, Inc. Covalently bound biological substances to plastic materials and use in radioassay
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
USRE34394E (en) * 1978-01-23 1993-09-28 Baxter Diagnostics Inc. Method and composition for double receptor, specific binding assays
JPS608745B2 (ja) * 1978-02-14 1985-03-05 三洋化成工業株式会社 免疫活性物質−つや消しガラス複合体，その製造法及び該複合体を含有してなる測定試薬
US4242322A (en) * 1978-06-07 1980-12-30 Electro-Nucleonics Laboratories, Inc. Methods and materials for detecting antigens and antibodies
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
ATE23169T1 (de) * 1983-07-21 1986-11-15 Scripps Clinic Res Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik.
EP0190205B1 (en) * 1984-07-24 1992-10-21 Coselco Mimotopes Pty. Ltd. Method for determining mimotopes
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5698686A (en) * 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
JP2002515965A (ja) * 1995-08-18 2002-05-28 ダブリュー． ランドリ，ドナルド 抗体触媒反応の調節による有機化合物の検出
US6689757B1 (en) 1996-02-12 2004-02-10 M.L. Laboratories Plc Methods for vaccination and vaccines therefor
US20020034732A1 (en) * 1997-07-30 2002-03-21 Daniel J. Capon Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
CN1230444C (zh) * 1998-11-16 2005-12-07 德克萨斯州立大学董事会 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
CN1484700A (zh) * 2000-11-02 2004-03-24 �¼��¹�����ѧ aopB基因,蛋白,同系物,片段和它们的变体,以及它们在细胞表面展示方面的应用
US7847084B2 (en) 2002-12-20 2010-12-07 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic Borrelia species and strains
WO2005035556A2 (en) * 2003-05-06 2005-04-21 Iguazu Biosciences Corp. Sars-coronavirus virus-like particles and methods of use
US7910523B2 (en) 2003-05-23 2011-03-22 Board Of Regents, The University Of Texas System Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
EP2368570A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
NZ578696A (en) 2007-02-02 2012-01-12 Baylor Res Inst Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
AU2008218184B2 (en) * 2007-02-02 2013-01-10 Baylor Research Institute Activation of human antigen-presenting cells through CLEC-6
WO2008097817A2 (en) * 2007-02-02 2008-08-14 Baylor Research Institute Multivariable antigens complexed with targeting humanized monoclonal antibody
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
JP2010518834A (ja) 2007-02-23 2010-06-03 ベイラー リサーチ インスティテュート 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化
JP2010519316A (ja) * 2007-02-23 2010-06-03 ベイラー リサーチ インスティテュート デクチン−１を介したヒト抗原提示細胞の活性化の治療への応用
US9138470B2 (en) * 2007-11-02 2015-09-22 The Johns Hopkins University Multi-component L2 vaccine for prevention of human papilloma virus infection
WO2010009346A2 (en) * 2008-07-16 2010-01-21 Baylor Research Institute Hiv vaccine based on targeting maximized gag and nef to dendritic cells
AU2009302582A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
SI3281947T1 (sl) 2009-04-03 2020-07-31 The University Of Chicago Sestave in metode v zvezi z variantami proteina A (SPA)
US10080799B2 (en) 2010-02-12 2018-09-25 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
CA2803298C (en) 2010-07-02 2020-07-14 The University Of Chicago Compositions and methods related to protein a (spa) variants
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
EP2633062B1 (en) 2010-10-29 2017-12-27 Life Technologies Corporation Biotin derivatives
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2013162746A1 (en) 2012-04-26 2013-10-31 University Of Chicago Staphylococcal coagulase antigens and methods of their use
US9701719B2 (en) 2012-09-27 2017-07-11 Research Development Foundation Attenuated Chikungunya virus
EP2964254B1 (en) 2013-03-07 2019-09-18 University of Maryland, Baltimore Immunotherapeutic potential of modified lipooligosaccharides/lipid a
CA3185180A1 (en) 2014-05-16 2015-11-19 Baylor Research Institute Methods and compositions for treating autoimmune and inflammatory conditions
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
US11413336B2 (en) 2018-03-23 2022-08-16 Board Of Regents, The University Of Texas System Coccidioides antigens and methods of their use
US11548938B2 (en) 2018-08-21 2023-01-10 Quidel Corporation DbpA antibodies and uses thereof
JP7640466B2 (ja) 2019-03-27 2025-03-05 アンスティチュート、ナシオナル、ドゥ、ラ、サンテ、エ、ドゥ、ラ、ルシェルシュ、メディカル Ｃｄ４０活性化特性を有する組換えタンパク質
US20230034677A1 (en) 2019-11-21 2023-02-02 INSERM (Institut National de la Santé et la Recherche (Médicale) Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines
US11376320B2 (en) 2020-03-05 2022-07-05 Iowa State University Research Foundation, Inc. Immunogenic and vaccine compositions against SARS-CoV-2
US20230183366A1 (en) 2020-05-13 2023-06-15 Inserm (Institut National De La Santé Et De La Recherch Médicale) Recombinant proteins with ox40 activating properties
WO2023144779A1 (en) 2022-01-28 2023-08-03 Pfizer Inc. Coronavirus antigen variants
WO2025017036A1 (en) 2023-07-17 2025-01-23 Institut National de la Santé et de la Recherche Médicale Alphavirus nsp3 helical tubular scaffolds
WO2025027492A1 (en) 2023-07-31 2025-02-06 Pfizer Inc. Coronavirus antigen variants
WO2025257397A1 (en) 2024-06-14 2025-12-18 Institut National de la Santé et de la Recherche Médicale Live attenuated bordetella vaccines capable of producing and secreting heterologous antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (cg-RX-API-DMAC7.html) * 1967-05-23 1971-08-02 Pharmacia Ab
SE343210B (cg-RX-API-DMAC7.html) * 1967-12-20 1972-03-06 Pharmacia Ab
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies

Also Published As

Publication number Publication date
DE2450523B2 (de) 1976-10-07
JPS5762020B2 (cg-RX-API-DMAC7.html) 1982-12-27
JPS5075095A (cg-RX-API-DMAC7.html) 1975-06-20
DE2450523A1 (de) 1975-05-22
FR2249334B1 (cg-RX-API-DMAC7.html) 1977-03-25
ES431413A1 (es) 1976-10-16
USRE29955E (en) 1979-04-03
AU476619B2 (en) 1976-09-30
SE7413484L (cg-RX-API-DMAC7.html) 1975-04-28
ZA746098B (en) 1975-11-26
AU7378774A (en) 1976-04-01
NL7413552A (nl) 1975-04-29
FR2249334A1 (cg-RX-API-DMAC7.html) 1975-05-23
IL45707A (en) 1977-01-31
BR7408886A (pt) 1976-05-04
IL45707A0 (en) 1974-11-29
LU71027A1 (cg-RX-API-DMAC7.html) 1975-04-17
CA1036493A (en) 1978-08-15
DE2450523C3 (de) 1978-06-22
US3949064A (en) 1976-04-06
GB1436934A (en) 1976-05-26

Similar Documents

Publication Publication Date Title
BE820660A (fr) Procede de detection d'antigenes ou d'anticorps
BE799417A (fr) Procede de direction et de determination d'haptenes,
RO63722A (fr) Procede de preparation de l'uree
BE795950A (fr) Procede de preparation d'amidosilanes
BE786518A (fr) Procede de preparation d'oxa-bicyclo-alcenes
BE754806A (fr) Procede pour l'isolation de proteines
FR2277891A1 (fr) Methode pour deceler par radio-immunometrie la presence d'anticorps de la blennorragie
CH554319A (fr) Procede de preparation d'aryl-guanidines ortho-disubstituees.
CH551437A (fr) Procede de preparation d'acides chromone-carboxyliques.
BE785344A (fr) Procede de preparation d'alcenyl-silanes
FR2290848A1 (fr) Procede d'isolement de proteines
BE752499A (fr) Procede de preparation d'amines secondaires ou
BE806124A (fr) Procede de preparation d'hydrazones
BE831145A (fr) Procede de dosage immunologique utilisant un systeme heterologue d'anticorps ou d'antigenes
BE774540A (fr) Procede de preparation de l'omega laurinolactame
BE809499A (fr) Procede et reactif pour le dosage de la creatinekinase
BE787014A (fr) Procede et reactif pour deceler la presence de l'antigene australien
BE811703A (fr) Procede de preparation d'isocyanato-triazines
RO62297A (fr) Procede de obtention d'un mixture proteique
BE792804A (fr) Procede de preparation d'hydroxocobalticorrinoide
BE786157A (fr) Procede de preparation de l'anhydride
BE779136R (fr) Procede de preparation d'acetoxy-1-methyl-3-butene-2-al-4
BE799405A (fr) Procede pour la purification d'antigene carcinoembryonnaire
BE781275A (fr) Procede de preparation d'o-aminobenzonitriles
BE798180A (fr) Procede de preparation d'anthracenes